Published in Farmaco Prat on April 01, 1979
Mixture experiment methods in the development and optimization of microemulsion formulations. J Pharm Biomed Anal (2011) 1.51
PAMELA measurements of cosmic-ray proton and helium spectra. Science (2011) 1.39
Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Ital J Gastroenterol Hepatol (1997) 1.38
Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood (1994) 1.30
Reduction incidence of myocardial infarction associated with a national legislative ban on smoking. Minerva Cardioangiol (2008) 1.25
Waldenström macroglobulinemia: a role of HCV infection? Blood (1993) 1.15
Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm (2004) 1.09
Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci (2013) 1.08
[Usefulness of biological markers in the evaluation of smoking at the first visit of a smoking cessation program]. Rev Mal Respir (2004) 1.07
An anomalous positron abundance in cosmic rays with energies 1.5-100 GeV. Nature (2009) 1.07
Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy. J Pharm Biomed Anal (1998) 1.00
Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci (2000) 0.96
Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev Ind Pharm (1999) 0.93
New measurement of the antiproton-to-proton flux ratio up to 100 GeV in the cosmic radiation. Phys Rev Lett (2009) 0.92
Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers. Drug Dev Ind Pharm (2004) 0.91
Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur J Pharm Biopharm (2005) 0.91
Development of enteric-coated timed-release matrix tablets for colon targeting. J Drug Target (2004) 0.90
Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells. Int J Pharm (2004) 0.89
[The quality of medical records: a retrospective study in Lazio Region, Italy]. Ann Ig (2004) 0.87
Evaluation of chemical stability of St. John's wort commercial extract and some preparations. Int J Pharm (2001) 0.87
Optimization of dissolution test precision for a ketoprofen oral extended-release product. J Pharm Biomed Anal (2003) 0.86
Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins. Drug Dev Ind Pharm (2001) 0.86
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques. J Pharm Biomed Anal (2005) 0.85
Hepatitis C virus risk: a hepatitis C virus related syndrome. J Intern Med (2000) 0.85
New "drug-in cyclodextrin-in deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm (2010) 0.84
Experimental design in the development of voltammetric method for the assay of omeprazole. J Pharm Biomed Anal (1996) 0.84
Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex. Eur J Pharm Sci (2008) 0.83
Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature. Eur J Clin Pharmacol (2014) 0.83
1,2-Cyclomethylenecarboxylic monoamide hydroxamic derivatives. A novel class of non-amino acid angiotensin converting enzyme inhibitors. J Med Chem (1993) 0.82
Physical characterization of picotamide monohydrate and anhydrous picotamide. J Pharm Sci (1999) 0.82
Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization. J Pharm Biomed Anal (2006) 0.81
[Preservability of rat serum in delayed determinations of some hematochemical parameters]. Boll Chim Farm (1972) 0.81
Enhancement of dehydroepiandrosterone solubility and bioavailability by ternary complexation with alpha-cyclodextrin and glycine. J Pharm Sci (2003) 0.81
Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis. Dig Liver Dis (2000) 0.81
Photostability studies on nicardipine-cyclodextrin complexes by capillary electrophoresis. J Pharm Biomed Anal (2004) 0.81
Formulation and characterization of triclosan sub-micron emulsions and nanocapsules. J Microencapsul (2004) 0.81
How experimental design can improve the validation process. Studies in pharmaceutical analysis. Anal Bioanal Chem (2003) 0.81
Scaling breakdown: a signature of aging. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 0.81
Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery. Eur J Pharm Biopharm (2011) 0.80
HCV genotypes and cryoglobulinemia. Clin Exp Rheumatol (1996) 0.80
Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components. Eur J Pharm Biopharm (2011) 0.79
Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation. Eur J Pediatr (1996) 0.79
Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia. Haematologica (1995) 0.79
Radiation shielding of spacecraft in manned interplanetary flights. Nucl Instrum Methods Phys Res A (2000) 0.79
Analysis and stability of the constituents of artichoke and St. John's wort tinctures by HPLC-DAD and HPLC-MS. Drug Dev Ind Pharm (2002) 0.79
Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex. Eur J Pharm Biopharm (2011) 0.79
Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. Int J Pharm (2007) 0.78
Identification by HPLC-DAD and HPLC-MS analyses and quantification of constituents of fennel teas and decoctions. J Agric Food Chem (2000) 0.78
Antimuscarinic drugs: traditional and potential new therapeutic agents. Pharmacol Res Commun (1982) 0.78
Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyclodextrins in solution. J Pharm Sci (1991) 0.77
Buflomedil is a potent interfering substance in immunoassays of tricyclic antidepressants. J Anal Toxicol (1998) 0.77
Response surface methodology in the optimization of chitosan-Ca pectinate bead formulations. Eur J Pharm Sci (2008) 0.77
Hepatitis A, B, C and D in a community in Italy of immigrants from NE Africa. J Public Health Med (1994) 0.77
PAMELA results on the cosmic-ray antiproton flux from 60 MeV to 180 GeV in kinetic energy. Phys Rev Lett (2010) 0.77
Cosmic-ray electron flux measured by the PAMELA experiment between 1 and 625 GeV. Phys Rev Lett (2011) 0.77
Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC. J Pharm Biomed Anal (2002) 0.77
Chlorophacinone intoxication. A biological and toxicological study. J Toxicol Clin Toxicol (1989) 0.76
Cosmic-ray positron energy spectrum measured by PAMELA. Phys Rev Lett (2013) 0.76
Influence of the preparation method on the physicochemical properties of binary systems of econazole with cyclodextrins. Int J Pharm (1999) 0.76
HCV and lymphoproliferative diseases. Clin Exp Rheumatol (1996) 0.76
Benzathine as a cause for a false-positive test result for amphetamines. J Pediatr (1995) 0.75
Storage study on acidic aqueous hexetidine solutions in polyolefinic and glass containers. Boll Chim Farm (1980) 0.75
Zinc contamination of control serum. Clin Chem (1979) 0.75
[In vitro study of some factors influencing the diffusion of oxytetracycline chloride from hard gelatin capsules]. Boll Chim Farm (1984) 0.75
Monitoring by headspace gaschromatography (HSGC) of formation and thermal stability of terpene beta-cyclodextrin complexes. Farmaco Prat (1986) 0.75
Radiation shielding of astronauts in interplanetary flights: the CREAM surveyor to Mars and the magnetic lens system for a spaceship. Phys Med (2001) 0.75
[In vitro studies on the rates of intestinal absorption of sparsely soluble drugs of different particle size]. Boll Chim Farm (1980) 0.75
Differential pulse polarographic determination of thiomersal transported through an artificial membrane simulating an isolated rabbit cornea. Boll Chim Farm (1980) 0.75
Analysis of plant complex matrices by use of nuclear magnetic resonance spectroscopy: St. John's wort extract. J Agric Food Chem (2001) 0.75
Improvement of dissolution characteristics of psoralen by cyclodextrins complexation. Farmaco (1995) 0.75
[New in vitro research in the field of corneal absorption by means of artificial membranes]. Farmaco Prat (1977) 0.75
Thermo-optical static and dynamic analysis of a digital optical switch based on amorphous silicon waveguide. Opt Express (2006) 0.75
Release of drugs in vitro from different dermatological preparations. Boll Chim Farm (1980) 0.75
[Derivatives of 1,3-diphenylpropanol and their pharmacologic properties]. Boll Chim Farm (1965) 0.75
[In-vitro transfer of oxytetracycline and doxycycline from various types of ointment excipients]. Boll Chim Farm (1976) 0.75
Pharmacokinetics and tissue distribution of cyclosporin (CsA) in methylprednisolone-treated rats. Acta Physiol Hung (1990) 0.75
Inclusion complex formation of 1,8-dihydroxyanthraquinone with cyclodextrins in aqueous solution and in solid state. J Pharm Sci (1988) 0.75
[Observing an SSU Em 118 dispatch center for continuous quality improvement. The case of SSUEm 118 Varese]. Minerva Anestesiol (2000) 0.75
[Synthesis and pharmaceutical findings on a series of amido derivatives of 3,4,5-trimethoxycinnamoyl acid and its analogs]. Boll Chim Farm (1967) 0.75
[The monitoring of cholinesterases in farm workers and tradesmen exposed to phosphoric esters and carbamates]. Med Lav (1992) 0.75
[In vitro studies of the diffusion of acetylsalicylic acid from various suppository excipients]. Farmaco Prat (1980) 0.75
[Rapid method for the identification of active ingredients of Cannabis using circular thin-layer chromatography]. Boll Chim Farm (1975) 0.75
[In-vitro study on the diffusion velocity constants of p-2-(n-octyloxy)-benzoyl-aminobenzoate of N-diethylmethylammonioethyl bromide]. Boll Chim Farm (1976) 0.75
Technical-regulatory aspects of antiseptics and disinfectants in Italy. J Chemother (1998) 0.75
Systemic passive transfer studies using IgM monoclonal antibodies to sulfatide. J Neuroimmunol (1995) 0.75
[Reaction of 1,2-diphenyl-4-bis-(methylthio)methylenepyrazolidin-3,5-dione with serine, cysteine and their derivatives]. Farmaco Sci (1975) 0.75
Evaluation of the dissolution behaviour of some commercial herbal drugs and their preparations. Pharmazie (2001) 0.75